Short Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Short Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants [NA]
Completed clinical trial evaluating enteral glutamine for reducing bloodstream infections in infants with short bowel syndrome; results post…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: The Use of DPP-4 Inhibitors in Short Bowel Syndrome [Phase 4]
Phase 4 trial exploring the use of DPP-4 inhibitors for Short Bowel Syndrome was terminated.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Use of Pancreatic Enzymes in Short Bowel Syndrome [Phase 2]
Phase 2 trial update on pancreatic enzymes for short bowel syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome [NA]
Clinical trial update for an amino acid–based oral rehydration solution in children with short bowel syndrome has terminated; results posted…
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS) [Phase 3]
Phase 3 study evaluating teduglutide in Japanese subjects with dependence on parenteral nutrition for short bowel syndrome has completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-05-16FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) by Takeda Pharmaceuticals America, expanding its labeling for short bow…
-
FDA approval · 2018-12-18FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies [Phase 2]
Phase 2 trial update evaluating early supplementation of enteral Microlipid with and without fish oil in premature infants with enterostomie…
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition [Phase 3]
Phase 3 clinical trial update for Short Bowel Syndrome in pediatric patients on parenteral nutrition; study completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2018-03-22Clinical Trial Update: SMOFLipid in Patients Who Are Intralipid Intolerant [Phase 4]
A Phase 4 clinical trial evaluating SMOFLipid in patients intolerant to Intralipid for home parenteral nutrition or short bowel syndrome has…
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome [Phase 4]
Phase 4 clinical trial update evaluating rtPA for prevention of central venous access device (CVAD) thrombosis and infection in pediatric pa…
-
FDA approval · 2017-07-12FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)
The FDA approved a supplemental application for PERTZYE (pancrelipase) from Digestive Care, Inc.
-
CLINICAL_TRIALS withdrawal · 2017-06-22Clinical Trial Update: Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease [Phase 1, Phase 2]
The Phase 1/2 trial evaluating oral fish oil for parenteral nutrition-associated liver disease sponsored by Boston Children's Hospital has b…
-
CLINICAL_TRIALS withdrawal · 2017-06-22Clinical Trial Update: Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome [Phase 2]
A Phase 2 trial comparing 70% ethanol to heparin to reduce central-line infections in children with Short Bowel Syndrome has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: A Phase 2 Trial Testing ZP1848 in Patients With SBS [Phase 2]
A Phase 2 trial of ZP1848 for Short Bowel Syndrome has completed, according to Zealand Pharma.
-
FDA approval · 2017-03-21FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) submitted by Takeda Pharmaceuticals America, Inc. This action approves …
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients [Phase 4]
Phase 4 clinical trial evaluating the preventative and therapeutic effects of ursodeoxycholic acid (UDCA) in Short Bowel Syndrome patients h…
-
CLINICAL_TRIALS research · 2017-01-27Clinical Trial Update: Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research [NA]
Clinical trial update reporting that the Home Parenteral Nutrition (HPN) Families’ Mobile Distance Connections to Care study has completed. …
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study [Phase 3]
A Phase 3 randomized, blinded crossover trial comparing loperamide to placebo for ileostomy output in patients with rectal cancer, ulcerativ…
-
FDA approval · 2016-05-27FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) from Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Diet/Growth Factor Mechanisms of Gut Adaptation [Phase 2]
A Phase 2 trial examining diet and growth factor mechanisms of gut adaptation in short bowel syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Comparison of Different Oral Rehydration Solutions [NA]
This clinical trial update reports a completed study comparing different oral rehydration solutions in Short Bowel Syndrome.
-
FDA approval · 2016-03-30FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for GATTEX (teduglutide) by Takeda Pharmaceuticals America, Inc., for the treatment of short bowel s…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications
A completed clinical trial from Xinhua Hospital/Shanghai Jiao Tong University studied intestinal microbial dysbiosis in Chinese infants with…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure
A completed clinical trial evaluated plasma glucagon-like peptide 2 as a predictor of recovery in adults with short bowel syndrome and acute…